Lightning Round OT: Owens Illinois, Vivus and More

Lightning Round OT
Lightning Round OT   

New Oriental Education : Take profits in EDU, Cramer said.

Owens-Illinois : OI is a buy, Cramer said.

Vivus :ImmunoGen is a better biotech speculation play, Cramer said.














Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Cramer's New Book